GenMark Diagnostics, Inc. GNMK
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.77B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 133.56
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2021
- 50-d avg
- 23.99
- 200-d avg
- 16.94
- 1y target
- 22.52
News
5 years ago gurufocus.com
GenomeWeb Index Drops 3% for 2nd Consecutive Month
Meridian Bioscience Inc. (NASDAQ:VIVO) edged out GenMark Diagnostics Inc. (NASDAQ:GNMK) as the top gainer in the March GenomeWeb Index with a 25% boost in its share price compared to GenMark's 22.5%…
5 years ago prnewswire.com
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm
NEW YORK, April 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Luminex Corporation (NASDAQ: LMNX) concerning…
5 years ago gurufocus.com
Italian Diagnostic Developer Calls Luminex a 'Perfect Fit'
Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 108 stocks made new 52-week highs.
5 years ago zacks.com
GenMark Diagnostics (GNMK) Enters Overbought Territory
GenMark Diagnostics (GNMK) has moved higher as of late, but there could definitely be trouble on the horizon for this company
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK
NEW YORK, March 19, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities…
5 years ago prnewswire.com
GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.
NEW YORK and SAN DIEGO, March 16, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics ("GenMark") (NASDAQ: GNMK) regarding possible…
5 years ago benzinga.com
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of…
5 years ago zacks.com
GenMark Diagnostics (GNMK) Soars 29.6%: Is Further Upside Left in the Stock?
GenMark Diagnostics (GNMK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…
5 years ago fool.com
Why GenMark Stock Soared Today
A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.
5 years ago globenewswire.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout
WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. (“GenMark”) (NASDAQ GM: GNMK) regarding possible breaches of…
5 years ago schaeffersresearch.com
GNMK Grabs Fresh Highs on Billion-Dollar Buyout Buzz
GenMark Diagnostics Inc (NASDAQ:GNMK) stock is surging today, up 29.1% to trade at $23.88 at last check, after news of its buyout.
5 years ago prnewswire.com
SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc.
NEW YORK, March 15, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics, Inc.…
5 years ago globenewswire.com
GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.
NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding…
5 years ago businesswire.com
GenMark Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GenMark Diagnostics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GNMK
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of GenMark Diagnostics, Inc. (NASDAQ: GNMK) to Roche is fair to GenMark shareholders.…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
On Monday morning, 415 companies achieved new highs for the year.
5 years ago barrons.com
GenMark Shares Surge After Roche Announces $1.8 Billion Deal for Molecular Test Maker
Shares of U.S.-based GenMark were shooting higher on Monday, after Swiss pharmaceutical group Roche said it will buy the California-based company.
5 years ago zacks.com
Roche (RHHBY) Inks Deal to Acquire GenMark Diagnostics for $1.8B
Roche (RHHBY) signs an agreement to acquire GenMark Diagnostics to test a broad range of pathogens using one patient sample. The deal is valued at around $1.8 billion on a fully diluted basis.
5 years ago pulse2.com
GNMK Stock Price Increases Over 25% Pre-Market: Why It Happened
The stock price of GenMark Diagnostics, Inc (NASDAQ: GNMK) is trading at over 25% pre-market. This is why it happened.
5 years ago invezz.com
Roche to buy U.S. based GenMark Diagnostics for £1.29 billion
Roche Holding AG (SWX: RO) said on Monday that it will buy GenMark Diagnostics (NASDAQ: GNMK) for £1.29 billion. The all-cash deal translates to £17.25 per share.
5 years ago benzinga.com
Roche Boosts Diagnostics Portfolio With $1.8B Bet On COVID-19 Test Manufacturer GenMark
Swiss drug giant Roche Holding AG (OTC: RHHBY) announced a big-ticket acquisition that would boost its presence in the diagnostics market, setting the tempo for a merger Monday. What Happened: Roche…
5 years ago reuters.com
Roche agrees to buy GenMark Diagnostics in $1.8 billion deal
Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a $1.8 billion deal, the Swiss pharmaceuticals manufacturer said on Monday.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 394 companies hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Wednesday's morning session saw 274 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 140 companies set new 52-week highs.
-
6 years ago benzinga.com
65 Biggest Movers From Yesterday
Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after surging around 22% on Friday.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday